- “FDA denies approval of King, Acura’s pain drug” (Reuters)
- “J&J to invest $1.5 bln in Elan in Alzheimer’s deal” (Market Watch)
- “WYETH PHARMACEUTICALS and CATALYST BIOSCIENCES announce agreement to develop and commercialize factor VIIa products” (Press release issued by Wyeth Pharmaceuticals and Catalyst Biosciences, WebWire)
- “GlaxoSmithKline Acquires Branded Generics Business Of Bristol Myers Squibb In 5 Countries – Update” (RTT News)
- “Sanofi-Aventis arrhythmia drug Multaq approved” (Forbes)
- “Chantix and Zyban Get Boxed Warnings” (Pharmaceutical Executive)
- “Life Without Vicodin Will Be OK, Docs Say” (ABC News)
- “Bayer Files Patent Infringement Lawsuit Against Teva” (The Wall Street Journal)
- “Europe biotechs see light at end of funding tunnel” (Reuters)
- “GSK spends £23.2 million to bag B-MS products in Middle East” (Pharma Times)
- “Acura, King get FDA response on Acurox” (Market Watch)
- “Sanofi-Aventis gets heart disease treatment approved” (Hays Pharma)
- “Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer” (Press release issued by Graceway Pharmaceuticals, PharmiWeb)
THE LATEST WORD
Top Industry Stories – July 2, 2009
Posted on July 2nd, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics